Response to Stephane Renaud et al.

We appreciate the comments in the letter to the editor. The letter addressed that specific KRAS mutation in non-small cell lung cancer (NSCLC) patients with brain metastases is associated with worse response to radiotherapy [1], and it might cause bias in our results from a retrospective cohort.

http://ift.tt/2ld5NTu